Maravai Lifesciences Holdings Stock Current Valuation
| MRVI Stock | USD 2.27 0.13 5.42% |
Valuation analysis of Maravai Lifesciences helps investors to measure Maravai Lifesciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The Maravai Lifesciences' current Enterprise Value is estimated to increase to about 3.1 B, while Enterprise Value Over EBITDA is forecasted to increase to (2.82). Fundamental drivers impacting Maravai Lifesciences' valuation include:
Fairly Valued
Today
Please note that Maravai Lifesciences' price fluctuation is dangerous at this time. Calculation of the real value of Maravai Lifesciences is based on 3 months time horizon. Increasing Maravai Lifesciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Maravai Lifesciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Maravai Stock. However, Maravai Lifesciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.27 | Real 2.33 | Target 9.07 | Hype 2.43 | Naive 2.73 |
The intrinsic value of Maravai Lifesciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Maravai Lifesciences' stock price.
Estimating the potential upside or downside of Maravai Lifesciences Holdings helps investors to forecast how Maravai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Maravai Lifesciences more accurately as focusing exclusively on Maravai Lifesciences' fundamentals will not take into account other important factors: Maravai Lifesciences Holdings Company Current Valuation Analysis
Maravai Lifesciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Maravai Lifesciences Current Valuation | 403.37 M |
Most of Maravai Lifesciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maravai Lifesciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Maravai Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Maravai Lifesciences is extremely important. It helps to project a fair market value of Maravai Stock properly, considering its historical fundamentals such as Current Valuation. Since Maravai Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Maravai Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Maravai Lifesciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Maravai Current Valuation Historical Pattern
Today, most investors in Maravai Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Maravai Lifesciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Maravai Lifesciences current valuation as a starting point in their analysis.
Maravai Lifesciences Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Maravai Lifesciences Holdings has a Current Valuation of 403.37 M. This is 97.19% lower than that of the Life Sciences Tools & Services sector and 91.32% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.57% higher than that of the company.
Maravai Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maravai Lifesciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics of similar companies.Maravai Lifesciences is currently under evaluation in current valuation category among its peers.
Maravai Lifesciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Maravai Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Maravai Lifesciences' managers, analysts, and investors.Environmental | Governance | Social |
Maravai Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.0364 | ||||
| Profit Margin | (0.56) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 403.37 M | ||||
| Shares Outstanding | 143.65 M | ||||
| Shares Owned By Insiders | 1.18 % | ||||
| Shares Owned By Institutions | 98.52 % | ||||
| Number Of Shares Shorted | 10.3 M | ||||
| Price To Earning | 7.79 X | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 2.36 X | ||||
| Revenue | 259.19 M | ||||
| Gross Profit | 108.31 M | ||||
| EBITDA | (156.92 M) | ||||
| Net Income | (259.62 M) | ||||
| Cash And Equivalents | 617.45 M | ||||
| Cash Per Share | 4.69 X | ||||
| Total Debt | 37.34 M | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 7.22 X | ||||
| Book Value Per Share | 2.29 X | ||||
| Cash Flow From Operations | 7.46 M | ||||
| Short Ratio | 2.49 X | ||||
| Earnings Per Share | (1.05) X | ||||
| Price To Earnings To Growth | (0.22) X | ||||
| Target Price | 8.34 | ||||
| Market Capitalization | 610.41 M | ||||
| Total Asset | 1.01 B | ||||
| Retained Earnings | 140.89 M | ||||
| Working Capital | 372.18 M | ||||
| Net Asset | 1.01 B |
About Maravai Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maravai Lifesciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:Check out Maravai Lifesciences Piotroski F Score and Maravai Lifesciences Altman Z Score analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.